Variation in CAD Secondary Prevention Prescription Among Outpatient Cardiology Practices: Insights From the NCDR®

Study Questions:

What is the practice variation of secondary prevention medication prescription (statins, beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin-receptor blockers) among coronary artery disease (CAD) patients treated in outpatient practices?